# STAT+: FDA is urged by advocacy group to ban DTC prescription drug ads
Canonical URL: https://biopharmsignal.com/news/MARKET/stat-fda-is-urged-by-advocacy-group-to-ban-dtc-prescription-drug-ads-e2d6e7b3
Ticker: MARKET
Company: MARKET
Source: STAT News
Published: 2026-07-23 13:00 EST
Original Source URL: https://www.statnews.com/pharmalot/2026/07/23/fda-urged-by-advocacy-group-to-ban-dtc-prescription-drug-ads/?utm_campaign=rss
## Summary

A leading advocacy group petitioned the FDA to ban direct-to-consumer advertising of prescription medicines.

## Article Body
By Ed Silverman

July 23, 2026

Pharmalot Columnist, Senior Writer

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter .

A leading advocacy group petitioned the U.S. Food and Drug Administration to ban direct-to-consumer advertising of prescription medicines, a move that comes as the Trump administration leans on drugmakers to provide more balanced information in their ads.

In arguing its case, Public Citizen maintained that director-to-consumer, or DTC, ads often “mislead consumers because they are designed to persuade rather than to inform or educate patients.” The ads sometimes “employ emotional manipulation techniques or visual distractions to highlight information about benefits” while minimizing risks.

The advocacy group hopes to persuade the FDA after the Trump administration last September announced a “ crackdown ” on what it called deceptive drug advertising. At the time, the administration disclosed plans for new rules and stronger enforcement, which was followed by dozens of letters sent to companies regarding problems with their ads.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
## Recent Company News
- 2026-07-23 16:33 EST — [STAT+: European regulators take steps to bolster clinical trial transparency](https://biopharmsignal.com/news/MARKET/stat-european-regulators-take-steps-to-bolster-clinical-trial-transparency-73aade26) — Source: STAT News
- 2026-07-23 16:23 EST — [STAT+: Popular insulin product enters shortage as other pens leave market](https://biopharmsignal.com/news/MARKET/stat-popular-insulin-product-enters-shortage-as-other-pens-leave-market-c3a6a199) — Source: STAT News
- 2026-07-23 16:18 EST — [Senate health panel delays vote on CDC nominee](https://biopharmsignal.com/news/MARKET/senate-health-panel-delays-vote-on-cdc-nominee-6cfcdaaa) — Source: STAT News
- 2026-07-23 15:26 EST — [STAT+: What’s in the last-minute flurry of health care bills?](https://biopharmsignal.com/news/MARKET/stat-what-s-in-the-last-minute-flurry-of-health-care-bills-39fec163) — Source: STAT News
- 2026-07-23 14:58 EST — [FDA panel confronting peptide controversy](https://biopharmsignal.com/news/MARKET/fda-panel-confronting-peptide-controversy-b9e91564) — Source: STAT News
## Related News
- 2026-07-23 16:33 EST — MARKET — [STAT+: European regulators take steps to bolster clinical trial transparency](https://biopharmsignal.com/news/MARKET/stat-european-regulators-take-steps-to-bolster-clinical-trial-transparency-73aade26)
- 2026-07-23 16:30 EST — BRLI — [OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026](https://biopharmsignal.com/news/BRLI/opko-health-to-report-second-quarter-2026-financial-results-on-july-27-2026-4b38e04c)
- 2026-07-23 16:23 EST — MARKET — [STAT+: Popular insulin product enters shortage as other pens leave market](https://biopharmsignal.com/news/MARKET/stat-popular-insulin-product-enters-shortage-as-other-pens-leave-market-c3a6a199)
- 2026-07-23 16:18 EST — MARKET — [Senate health panel delays vote on CDC nominee](https://biopharmsignal.com/news/MARKET/senate-health-panel-delays-vote-on-cdc-nominee-6cfcdaaa)
- 2026-07-23 15:26 EST — MARKET — [STAT+: What’s in the last-minute flurry of health care bills?](https://biopharmsignal.com/news/MARKET/stat-what-s-in-the-last-minute-flurry-of-health-care-bills-39fec163)